Antiviral research · 2021
Proteomic analysis identifies the RNA helicase DDX3X as a host target against SARS-CoV-2 infection.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ciccosanti Fabiola, Di Rienzo Martina, Romagnoli Alessandra, Colavita Francesca, Refolo Giulia, Castilletti Concetta, Agrati Chiara, Brai Annalaura, Manetti Fabrizio, Botta Lorenzo, Capobianchi Maria Rosaria, Ippolito Giuseppe, Piacentini Mauro, Fimia Gian Maria
Аннотация
COVID-19 is currently a highly pressing health threat and therapeutic strategies to mitigate the infection impact are urgently needed. Characterization of the SARS-CoV-2 interactome in infected cells may represent a powerful tool to identify cellular proteins hijacked by viruses for their life cycle and develop host-oriented antiviral therapeutics. Here we report the proteomic characterization of host proteins interacting with SARS-CoV-2 Nucleoprotein in infected Vero E6 cells. We identified 24 high-confidence proteins mainly playing a role in RNA metabolism and translation, including RNA helicases and scaffold proteins involved in the formation of stress granules, cytoplasmic aggregates of messenger ribonucleoproteins that accumulate as a result of stress-induced translation arrest. Analysis of stress granules upon SARS-CoV-2 infection showed that these structures are not induced in infected cells, neither eIF2α phosphorylation, an upstream event leading to stress-induced translation inhibition. Notably, we found that G3BP1, a stress granule component that associates with the Nucleoprotein, is required for efficient SARS-CoV-2 replication. Moreover, we showed that the Nucleoprotein-interacting RNA helicase DDX3X colocalizes with viral RNA foci and its inhibition by small molecules or small interfering RNAs significantly reduces viral replication. Altogether, these results indicate that SARS-CoV-2 subverts the stress granule machinery and exploits G3BP1 and DDX3X for its replication cycle, offering groundwork for future development of host-directed therapies.
Предметные рубрики MeSH
AnimalsAntiviral AgentsCOVID-19Cell LineChlorocebus aethiopsDEAD-box RNA HelicasesDNA HelicasesEukaryotic Initiation Factor-2Host-Pathogen InteractionsHumansPoly-ADP-Ribose Binding ProteinsProteomicsRNA HelicasesRNA Recognition Motif ProteinsRNA, Small InterferingRNA, ViralSARS-CoV-2Vero CellsVirus ReplicationCOVID-19 Drug Treatment